Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10357	Companies
215527	Keywords
145336	Articles
114173	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 04/13/2026 at 14:30, 23 days 16 hours ago

Artificial Intelligence (AI) Platforms Could Enhance Jaguar Health's Development and Anticipated Commercialization of Crofelemer for Rare Disease Intestinal Failure (IF) Programs
Jaguar Health plans to utilize AI platforms to enhance the development and commercialization of crofelemer for intestinal failure treatment, targeting ultrarare pediatric disorder MVID

Crofelemer Jaguar Health MVID AI Platforms Intestinal Failure
BRIEF

published on 04/10/2026 at 02:20, 27 days 4 hours ago

Jaguar Health Schedules Investor Webcast on Q4 2025 Financials

Financial Updates Forward-looking Statements Investor Webcast Jaguar Health Gastrointestinal Treatments
BRIEF

published on 04/10/2026 at 02:20, 27 days 4 hours ago

Jaguar Health programme une webdiffusion pour les investisseurs sur ses résultats financiers du quatrième trimestre 2025.

Jaguar Health Déclarations Prospectives Actualités Financières Webinaire Pour Les Investisseurs Traitements Gastro-intestinaux
PRESS RELEASE

published on 04/10/2026 at 02:15, 27 days 4 hours ago

Reminder: Jaguar Health to Host Investor Webcast at 8:30 am Eastern on Friday, April 10, 2026 Regarding Q4 2025 Financials and Company Updates
Jaguar Health, Inc. announces participation details for upcoming webcast on April 10, 2026. Learn about their novel prescription drugs derived from plants for GI diseases

Forward-looking Statements Webcast Jaguar Health GI Diseases Prescription Drugs
BRIEF

published on 04/08/2026 at 14:35, 28 days 16 hours ago

Jaguar Health achève l'essai du Crofelemer pour le CID chez les chiens

Crofelemer Jaguar Health Approbation De La FDA Chimiothérapie Canine Traitement De La Diarrhée
BRIEF

published on 04/08/2026 at 14:35, 28 days 16 hours ago

Jaguar Health Completes Crofelemer Trial for CID in Dogs

Crofelemer FDA Approval Jaguar Health Dog Chemotherapy Diarrhea Treatment
PRESS RELEASE

published on 04/08/2026 at 14:30, 28 days 16 hours ago

Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar Health, Inc. completes study on crofelemer for cancer therapy-induced diarrhea in dogs. Results expected to complement positive outcomes. Company plans to file effectiveness study by Q2 2026

Crofelemer Jaguar Health Cancer Therapy Diarrhea Dogs
BRIEF

published on 04/07/2026 at 14:35, 29 days 16 hours ago

Jaguar Health annonce des résultats financiers mitigés pour 2025

Jaguar Health Résultats Financiers 2025 Appel Du Nasdaq Accord Futur Sur Le Pakistan Médicaments Crofelemer
BRIEF

published on 04/07/2026 at 14:35, 29 days 16 hours ago

Jaguar Health Reports Mixed Financial Results for 2025

Jaguar Health Financial Results 2025 Crofelemer Drugs Nasdaq Appeal Future Pak Agreement
PRESS RELEASE

published on 04/07/2026 at 14:30, 29 days 16 hours ago

Jaguar Health Reports 2025 Financials
Jaguar Health, Inc. reports a 5% increase in net revenue in Q4 2025 compared to Q3 2025. Company receives $16M upfront payment from Future Pak for license agreement. Financial results include revenue breakdown and operational expenses

Financial Results Jaguar Health License Agreement Q4 2025 Net Revenue Increase

Accesswire

Published on 05/07/2026 at 05:40, 1 hour 28 minutes ago

New Horizon Aircraft Ltd. Announces Pricing of $20 Million Offering of Common Shares
Published on 05/07/2026 at 02:00, 5 hours 8 minutes ago

Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 7 hours 38 minutes ago

Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 8 hours 3 minutes ago

Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 8 hours 8 minutes ago

Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 06:30, 38 minutes ago

Avolta reports a positive first quarter 2026, proving its resilience
Published on 05/07/2026 at 06:30, 38 minutes ago

Siegfried included in Dow Jones Best-in-Class Europe Index
Published on 05/07/2026 at 06:15, 53 minutes ago

Bison Bank, wholly owned by Hong Kong's Bison Capital, launches its MiCA-compliant stablecoin for institutional cross-border payments
Published on 05/07/2026 at 04:00, 3 hours 8 minutes ago

L’Université chinoise de Hong Kong (CUHK) se classe en tête à Hong Kong et en Asie dans le dernier classement mondial des universités par discipline publié par QS (Quacquarelli Symonds)
Published on 05/07/2026 at 04:00, 3 hours 8 minutes ago

CUHK Claims Top Positions in Hong Kong and Asia in the Latest QS World University Rankings by Subject

Les Echos

Published on 05/06/2026 at 18:00, 13 hours 8 minutes ago

Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 13 hours 8 minutes ago

Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 13 hours 8 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 13 hours 8 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 13 hours 23 minutes ago

Information concerning the total number of voting rights and shares 2026 04 30

View all LES ECHOS COMFI WIRE